Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

22nd Century Group (XXII)

XXII RSS Feed
Add XXII Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Tamtam, KarinCA, PinkieSwear, TOB, jockinmikeg, Grape Ape
Search This Board:
Last Post: 11/21/2014 3:06:38 PM - Followers: 223 - Board type: Free - Posts Today: 31

22nd Century Group Inc.

 

data:image/jpeg;base64,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


Ticker: XXII
(NYSE MKT)

Share Structure from latest 10-K:
O/S - 59,601,688 as of 8/11/14
Float - 39,500,000 as of 1/31/14

                                                                                                                                                                                                                                                                                                                        
                                                                                                                          
 
22nd Century is a plant biotechnology company whose proprietary technology through genetic engineering and plant breeding allows (i) the level of nicotine (and other nicotinic alkaloids) in the tobacco plant to be decreased or increased and (ii) the levels of cannabinoids to be decreased or increased, in addition to the cannabinoid profile being tailored. 22nd Century owns or is the exclusive licensee of 129 issued patents in 78 countries plus an additional 51 pending patent applications, and 22nd Century has co-exclusive rights to another 16 patent applications. Goodrich Tobacco is focused on commercial tobacco products and potential less harmful cigarettes. Botanical Genetics is focused on novel, cannabis plant varieties and cannabis-based products for human health, well-being and nutrition, in addition to industrial products refined from cannabis. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development.

Editorial Opinion: "Patented and BAT-licensed altered nicotine technology that will disrupt a $700B Worldwide Tobacco Industry with 5 different revenue streams on both the consumer product and pharmaceutical side of smoking cessation, cannabis, and modified risk tobacco products - $1B+ mkt cap potential"
 

www.xxiicentury.com

XXII PIPELINE                               XXII TECHNOLOGY                            XXII PRODUCTS



 

Research and Recent News:



Chardan Capital Markets Analyst Reports 1/10/14    1/31/14    2/10/14   3/17/14    4/2/14    4/21/14    7/15/14   9/23/14   10/1/14


XXII RESEARCH REPORT - HTFBSN "Light This Fuse"


HTFBSN 22nd Century Group CEO Interview - November 2013
 

22nd Century Group to Acquire Participating Member of the Tobacco Master Settlement Agreement (MSA) - Sept 18, 2013
 

British American Tobacco Licenses 22nd Century Group Technology - Oct 1, 2013

22nd Century Group Warrant Exchange Eliminates 93% of Warrant Liability - Dec 16, 2013


22nd Century Group Files Annual Report and Provides Business Update - Jan. 30, 2014


22nd Century Group Approved to List Common Stock in NYSE MKT - Mar. 6, 2014


22nd Century Subsidiary Goodrich Tobacco Company Granted Federal Permit to Manufacture Tobacco Products - Mar. 10, 2014


22nd Century Group Files $45M Shelf Registration and Provides Business Update - Apr. 21, 2014


22nd Century Group Signs Letter of Intent w/ European Factory for Production of Nicotine-Free Cigarettes in Europe - May 29, 2014


22nd Century Group Added to Russell 3000, 2000, Global, and Microcap Indexes - Jun. 30, 2014


22nd Century Group Engages CRO for FDA Regulatory Activities for Company's Modified Risk Cigarettes - Jul. 11, 2014


22nd Century Group Partner NASCO Enters Agreement with Smoker Friendly International - Aug. 29, 2014


22nd Century Group Becomes Member of Tobacco Master Settlement Agreement (MSA) - Sep. 2, 2014


22nd Century Enters Cannabis Space - Sep. 18, 2014


22nd Century Granted Meeting w/FDA to Advance Development of a Potential Modified Risk Cigarette - Sep. 25, 2014


XXII Current Stock Chart:


 To learn more about 22nd Century Brands
Visit the links and images below:
         
                      GOLD MAGIC CIGARETTES                                                                                                    RED SUN CIGARETTES





 

                                                                    Home Dutch-

 
 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
XXII
Current Price
Volume:
Bid Ask Day's Range
Wiki
News News Alert: 22nd Century Group to Hold Conference Call to Provide Business Update For Investors 11/21/2014 12:41:00 PM
PostSubject
#19503  Sticky Note http://seekingalpha.com/pr/11788555-22nd-century-group-to-hold-conference-call-t parinvestor 11/21/14 12:42:49 PM
#15054  Sticky Note XXII responds to SA article vangorilla 08/27/14 03:24:26 PM
#13282  Sticky Note 22nd Century Group Added to Russell 3000, Russell TOB 07/01/14 12:20:30 PM
#19527   I'd like to take credit for starting this doccjc 11/21/14 03:06:37 PM
#19526   What Henry is doing very courageous. It is selinpinar 11/21/14 03:05:20 PM
#19525   exactly. Its a call for investors. Thats all gary122 11/21/14 03:04:10 PM
#19524   Ok, lets just enjoy the ride up now! ztockings 11/21/14 02:53:15 PM
#19523   MM's "middling" a lot of shares here between Atlanta1 11/21/14 02:49:47 PM
#19522   "Don't discount perker." -Vangorilla damaniac311 11/21/14 02:40:13 PM
#19521   Could be. Usually we hear about these jockinmikeg 11/21/14 02:25:33 PM
#19520   That's usually how they like to do things. Lnp30 11/21/14 02:20:31 PM
#19519   Consensus is that Bonnie is waiting for news doccjc 11/21/14 02:08:13 PM
#19518   That's exactly what I'm speculating - that the Atlanta1 11/21/14 02:04:37 PM
#19517   Wish I can join but I'm all out. ztockings 11/21/14 02:03:16 PM
#19516   All hail Henry! nick31 11/21/14 02:00:23 PM
#19515   They already have a presentation scheduled at the Atlanta1 11/21/14 01:55:48 PM
#19514   They can't release material news at a conference jockinmikeg 11/21/14 01:53:24 PM
#19513   I liked this comment. "Henry Sicignano stated, We believe Apparition 11/21/14 01:52:02 PM
#19512   I'm guessing that there may be some speculation Atlanta1 11/21/14 01:48:53 PM
#19511   yep - buying all I can right now. Atlanta1 11/21/14 01:39:58 PM
#19510   Very much looking forward to hearing Henry's voice. doccjc 11/21/14 01:36:56 PM
#19509   Something to look forward to...I have a very ztockings 11/21/14 01:19:30 PM
#19508   This will be Henry speaking - not Joe. Atlanta1 11/21/14 01:18:40 PM
#19507   Thanks! I think this is just the type of parinvestor 11/21/14 01:02:10 PM
#19506   Think I'm going back in for a few doccjc 11/21/14 12:58:45 PM
#19505   Thanks for the Conference Call link. Made jockinmikeg 11/21/14 12:58:10 PM
#19504   Ahhh, definitely more buyers coming in. I'm ztockings 11/21/14 12:45:51 PM
#19503   http://seekingalpha.com/pr/11788555-22nd-century-group-to-hold-conference-call-t parinvestor 11/21/14 12:42:49 PM
#19502   Buy/Sell volume is 3/2. Definitely more buyers jockinmikeg 11/21/14 11:40:45 AM
#19501   Looking good IMO. Apparition 11/21/14 11:29:52 AM
#19500   Still quite a few selling... ztockings 11/21/14 11:21:18 AM
#19499   Pre-market is 1.84/5$. This might be the first _VincentP_ 11/21/14 09:31:38 AM
#19497   Yes. And a great place to board. macnqueso 11/21/14 04:28:12 AM
#19494   BULLISH THREE GAP DOWNS penny chaser 11/20/14 06:53:53 PM
#19493   Long ride here nymostwanted 11/20/14 06:29:19 PM
#19491   Great point... that makes six possible revenue strains.... macnqueso 11/20/14 05:28:02 PM
#19490   14 Day RSI at 30% close. $1.69 support Apparition 11/20/14 04:23:09 PM
#19488   And the 4 opportunities don't include China or timorr 11/20/14 03:45:02 PM
#19487   Great posting macnqueso Diesenei 11/20/14 03:19:48 PM
#19486   True dat... and ignoring the current valuations of macnqueso 11/20/14 02:14:10 PM
#19485   And hasn't sold any... That should be a ztockings 11/20/14 01:25:50 PM
#19484   I read on Morningstar that 2.2 million shares strut1702 11/20/14 01:14:44 PM
#19483   KarinCA the reason could very well be... TTommy 11/20/14 01:01:32 PM
#19482   I believe the $10 million is just for ztockings 11/20/14 12:31:43 PM
#19481   Xxii and the N/L? Missed the post. Lnp30 11/20/14 11:41:24 AM
#19480   I have never read a newsletter about this KarinCA 11/20/14 11:39:05 AM
#19479   Every time I look at Chardan's valuation of damaniac311 11/20/14 11:35:14 AM
#19477   I need more $$$ to load up... nymostwanted 11/20/14 10:32:20 AM
#19471   Not to change the subject,Van,but can you shed keltoi 11/20/14 09:55:35 AM
#19469   Agreed gary...$10 mill isn't a lot of money Lnp30 11/20/14 09:31:37 AM
#19468   Risk being 0 is a very subjective view :) Lnp30 11/20/14 09:29:58 AM
#19465   yes, they invested 10 million. That doesn't mean gary122 11/20/14 09:12:55 AM
#19464   gary122 Oh yes it is just a good story, Diesenei 11/20/14 09:05:20 AM
PostSubject